Articles |
 Page 1 of 2  |
Company ends amdoxovir collaboration.
February 23, 2004
|
Risk factors for severe liver fibrosis identified.
February 23, 2004
|
Apheresis temporarily lowers viremia in patients with chronic hepatiti...
February 23, 2004
|
Hepatitis A vaccine provides immune memory 12 years after primary cour...
February 23, 2004
|
Experimental hepatitis C drug achieves favorable safety profile.
February 23, 2004
|
Acidic pH stabilizes HEV capsid protein.
February 23, 2004
|
Hepatocellular carcinoma is detected in a TT virus-positive patient.
February 23, 2004
|
Hair dye is linked to the formation of hepatitis.
February 23, 2004
|
HCV core protein alters cell cycles to influence pathogenesis and onco...
February 23, 2004
|
Cluster analyses of the lamivudine resistance region reveals HBV genot...
February 23, 2004
|
Nucleotide changes in hepatitis C virus chimeras cause nonviable pheno...
February 23, 2004
|
Duck hepatitis B virus X proteins may not be involved in viral infecti...
February 23, 2004
|
Diagnostic testing company opens market in Caribbean.
February 23, 2004
|
Study shows large increase in deaths related to hepatitis C.
February 23, 2004
|
Guanosine assays can estimate the plasma biomarker guanine deaminase.
February 23, 2004
|
High rate of multiple viral infections in Argentina IDUs.
February 23, 2004
|
Consensus interferon beats out interferon-ribavirin regimens in HCV re...
February 23, 2004
|
Transient elastography offers a new noninvasive way to check liver fib...
February 23, 2004
|
A major Chinese weight loss supplement has been linked to liver injury...
February 23, 2004
|
Cyclooxygenase-2 inhibitors could be valuable for preventing liver can...
February 23, 2004
|
Interferon alters acute-phase reactions in patients treated for HCV in...
February 23, 2004
|
Apoptosis genes influence hepatitis C and B virus-related liver injury...
February 23, 2004
|
Diagnostics company completes acquisition of Virosure product line.
February 23, 2004
|
Early treatment response foreshadows good outcomes for patients with H...
February 16, 2004
|
Four heat shock proteins are biomarkers for HCV-related liver cancer.
February 16, 2004
|
Transgenic mice offer a new way to study hepatitis C virus immunopatho...
February 16, 2004
|
Exploratory phase II study: Gamma-1b is generally well tolerated.
February 16, 2004
|
Loss of TIP30 heightens susceptibility to tumor development.
February 16, 2004
|
Jennifer Giottonini named VP, corporate development.
February 16, 2004
|
Michael Markels to lead sales and marketing for neuropathic pain compa...
February 16, 2004
|
Hepatitis C virus subgenomic replicons can be grown in nonhepatic cell...
February 16, 2004
|
Viral kinetics elucidate therapeutic response in chronic hepatitis C p...
February 16, 2004
|
Patients with hepatitis B and C coinfections have a slightly higher ca...
February 16, 2004
|
Hepatitis B virus DNA integration occurs early during acute infection.
February 16, 2004
|
Gamma-linolenic acid infusion occludes vessels that feed tumors.
February 16, 2004
|
Antibody from liver disease patients slows oxidative muscle cell respi...
February 16, 2004
|
Hepatitis C virus core protein upregulates enzyme inhibitor to stop ap...
February 16, 2004
|
Interferon lowers the risk for liver cancer in patients with chronic h...
February 16, 2004
|
Treatment for HIV and HCV infections in hemophiliacs reviewed.
February 16, 2004
|
Typhoid/hepatitis A vaccine effective as booster dose in primed adults...
February 16, 2004
|
HBsAg variants break tolerance in hepatitis B surface antigen mice.
February 16, 2004
|
Chronic hepatitis C patients to benefit from guidance on new drugs and...
February 16, 2004
|
FIBOSpect II introduced for detection of liver fibrosis.
February 16, 2004
|
Rebetol Oral Solution available for treating pediatric hepatitis C.
February 16, 2004
|
Company completes independent test for hepatitis B in China.
February 16, 2004
|
Radiofrequency ablation and transcatheter chemoembolization are used f...
February 16, 2004
|
Geranylgeranylation blockade is a new strategy for treating hepatitis ...
February 16, 2004
|
Intrahepatic CD8 T-lymphocyte levels mark chronic hepatitis B treatmen...
February 16, 2004
|
Neutrophils govern T-cell recruitment and hepatitis formation.
February 16, 2004
|
Quantitative analyses illuminate ribavirin and HCV RNA polymerase bind...
February 16, 2004
|
Those treated for HCV-related cancer have better odds if inflammation ...
February 16, 2004
|
Interferon-gamma-inducible protein 10 denotes HCV-linked liver status.
February 09, 2004
|
The INNO-LiPA HBV identifies mixed genotypes in difficult samples.
February 09, 2004
|
Alcohol has a dose-dependent effect on endothelial adhesion molecules.
February 09, 2004
|
Endocrine factors underlie bone disease in cirrhotic men and women.
February 09, 2004
|
Lamivudine prevents HBV flare in leukemia patients treated with campat...
February 09, 2004
|
Hepatitis B virus X protein is involved in the etiology of liver cance...
February 09, 2004
|
Metabasis joins forces to develop hepatitis C therapeutic.
February 09, 2004
|
Hepatitis delta antigens cause varied immunity in mice.
February 09, 2004
|
Hepatitis B virus pre-S mutants flourish in countries with HBV endemic...
February 09, 2004
|
The etiology of liver steatosis is often virus-related.
February 09, 2004
|
Genomic-marker company completes $5.4 million series A financing.
February 09, 2004
|
Liver transplantation feasible in HIV/HCV-coinfected patients.
February 09, 2004
|
Two-dose hepatitis A vaccine effective in Thai children.
February 09, 2004
|
CHO cell clones expressing hepatitis B surface protein screened.
February 09, 2004
|
Hepatitis B infection appears to trigger adult-onset Still disease.
February 09, 2004
|
Preliminary testing of hepatitis B test kit meets expectations.
February 09, 2004
|
Hepatitis vaccine collaboration signed.
February 09, 2004
|
Phase I trials of Actilon initiated.
February 09, 2004
|
Company announces development of two new molecules to battle virus.
February 09, 2004
|
HEV-neutralizing antibodies recognize antigen of ORF2 protein vaccine.
February 09, 2004
|
Hepatitis C virus NS4 uses subversive tactics to thwart Th1 response.
February 09, 2004
|
Interleukin-18-binding protein staunches inflammatory response in mous...
February 09, 2004
|
Antisense suppression of DDEFL1 blocks hepatocellular carcinoma cell g...
February 09, 2004
|
Keratin polypeptide gene deletions heighten susceptibility to liver in...
February 09, 2004
|
| More
articles from Hepatitis Weekly... |
